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Abstract
Background—Results from studies examining the association between alcohol consumption and
the risk of Barrett’s esophagus have been inconsistent. We assessed the risk of Barrett’s esophagus
associated with total and beverage-specific alcohol consumption by pooling individual participant
data from five case-control studies participating in the international Barrett’s and Esophageal
Adenocarcinoma Consortium (BEACON).
Methods—For analysis there were 1282 population-based controls, 1418 controls with
gastroesophageal reflux disease (GERD) and 1169 patients with Barrett’s esophagus (cases). We
estimated study-specific odds ratios (OR) and 95% confidence intervals (95% CI) using
multivariable logistic regression models adjusted for age, sex, body mass index (BMI), education,
smoking status, and GERD symptoms. Summary risk estimates were obtained by random effects
models. We also examined potential effect modification by sex, BMI, GERD symptoms and
cigarette smoking.
Results—For comparisons with population-based controls, while there was a borderline
statistically significant inverse association between any alcohol consumption and the risk of
Barrett’s esophagus (any vs. none, summary OR=0.77, 95% CI 0.60–1.00), risk did not decrease in
a dose-response manner (ptrend=0.72). Among alcohol types, wine was associated with a
moderately reduced risk of Barrett’s esophagus (any vs. none, OR=0.71, 95% CI 0.52–0.98);
however, there was no consistent dose-response relationship (ptrend=0.21). We found no
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association with alcohol consumption when cases were compared with GERD controls. Similar
associations were observed across all strata of BMI, GERD symptoms and cigarette smoking.
Conclusions—Consistent with findings for esophageal adenocarcinoma, we found no evidence
that alcohol consumption increases the risk of Barrett’s esophagus.
Keywords
Esophageal cancer; etiology; risk factors; ethanol
INTRODUCTION
The incidence of esophageal adenocarcinoma continues to rise in the United States and other
Western populations (1); median survival time for this cancer remains less than 12 months
(2). Efforts to reduce morbidity and mortality from esophageal adenocarcinoma have
focused on screening and surveillance for Barrett’s esophagus, a metaplastic condition and
the only known precursor to esophageal adenocarcinoma (3). However, these efforts have
had very little population-level impact due to under-detection of patients with early
esophageal adenocarcinoma and over-detection of indolent Barrett’s esophagus, with
resultant uncertainty regarding the effectiveness of periodic surveillance (4).
Better strategies are needed to identify individuals for endoscopic screening for Barrett’s
esophagus, to clarify potentially modifiable risk or protective factors and to triage patients
with Barrett’s esophagus based on risk of carcinogenic progression. Multiple risk prediction
models for Barrett’s esophagus aim to address the former issue (5–9), but none have
performed well enough to warrant clinical application, in part due to uncertainty regarding
the accuracy of some exposure inputs.
The international Barrett’s and Esophageal Adenocarcinoma Consortium (BEACON; http://
beacon.tlvnet.net/) is a global resource that has amassed one of the largest and best
annotated collections of patients with esophageal adenocarcinoma and Barrett’s esophagus,
as well as population-based controls. To date, data from BEACON have been used to better
quantify the risk of Barrett’s esophagus conferred by obesity (10) and cigarette smoking
(11). However, an outstanding and especially confusing issue is the association between
alcohol consumption and the risk of Barrett’s esophagus. Despite previous investigation, it
remains unclear whether alcohol consumption is truly associated with risk of Barrett’s
esophagus, and whether patients’ alcohol histories may help improve risk stratification for
Barrett’s esophagus. Results from previous studies of alcohol and Barrett’s esophagus are
conflicting, with some studies reporting positive associations with moderate to heavy total
and/or beverage-specific consumption (12–15), and others reporting inverse associations
(16–20). However, many of these studies used different exposure categorizations, did not
evaluate alcohol subtypes, or had limited power to evaluate interactions between alcohol and
other risk factors. Therefore, we pooled individual participant data from five Barrett’s
esophagus case-control studies participating in BEACON to comprehensively evaluate the
association between alcohol consumption and the risk of Barrett’s esophagus.
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The five case-control studies participating in BEACON used for this analysis were: the
Study of Digestive Health (Brisbane, Australia) (18); the Factors Influencing the Barrett’s/
Adenocarcinoma Relationship (FINBAR) study (Ireland) (16); the Epidemiology and
Incidence of Barrett’s Esophagus study (Kaiser Permanente Northern California) (17); the
Study of Reflux Disease (western Washington State) (21); and the Epidemiologic Case-
Control Study of Barrett’s Esophagus (Chapel Hill, North Carolina). The Institutional
Review Boards or Research Ethics Committees of each institution approved the acquisition
and pooling of data for the present analysis. Participants provided written informed consent
to take part in the studies. Full details of recruitment and participation are provided in the
primary papers (16–18, 21).
We compared patients with Barrett’s esophagus (cases) with two separate control groups:
GERD controls (i.e., participants who had GERD symptoms or endoscopic evidence of
acute esophageal inflammation consistent with GERD) and population-based controls. Five
studies provided a GERD control group (see Table 1 ref #11); four studies provided
population-based controls (the Chapel Hill study did not have a population-based
comparison group). The definition of Barrett’s esophagus in each study included endoscopic
evidence of columnar mucosa in the tubular esophagus, accompanied by the presence of
specialized intestinal metaplasia in an esophageal biopsy. Overall, data were pooled for
1432 population-based controls, 1659 GERD controls, and 1320 cases. Among those
participants with available data on alcohol consumption (1376 population-based controls,
1597 GERD controls, and 1257 cases), we restricted our analyses to white non-Hispanic
study participants (1282 population-based controls, 1418 GERD controls, 1169 cases) due to
low numbers of cases from other ethnic groups (cases: 12 black, 32 Hispanic, 42 other, 2
missing).
Data collection
The main exposure was average daily alcohol consumption (drinks per day). Two studies
asked participants to report their ‘usual consumption of alcohol’ (21), two studies captured
alcohol consumption for the period one year (17) or five years before interview (16), and
one study assessed usual frequency of consumption of alcohol during the age intervals of
20–29 years, 30–49 years and ≥50 years (18); for this study we used the average across these
intervals for the pooled analysis. The beverage-specific analyses for consumption of beer,
wine (red or white), and liquor were conducted using data from four studies (the Chapel Hill
study did not collect beverage specific consumption) (16–18, 21).
Individual-level harmonized clinical, demographic, and questionnaire data for each study
participant were merged into a single de-identified dataset and included information on
study center, case-control status, age at diagnosis (or reference date for controls), sex,
ethnicity, body mass index (BMI; weight divided by height squared, kg/m2), education,
GERD symptoms status (ever vs. never), and cigarette smoking status (never, former,
current) and pack-years (continuous). The data were checked for consistency and
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completeness and any apparent inconsistencies were follow-up with individual study
investigators.
Statistical analysis
We assessed the association between alcohol consumption (in categories: none, >0–<0.5,
0.5–<1.0, 1–<3, 3–<5, 5–<7, ≥7 drinks/day) and risk of Barrett’s esophagus using a two-
stage analytic approach (22). In the first stage, study-specific odds ratios (OR) and
corresponding 95% confidence intervals (95% CI) were estimated using unconditional
logistic regression models adjusted for age (<50, 50–59, 60–69, ≥70 years), sex, education
(school only, technical college/diploma, university/college), BMI (<25, 25–29.9, ≥30
kg/m2), smoking status (never, former, current), and GERD symptoms (ever vs. never;
population-based control comparisons only). Study-specific analyses for the Chapel Hill
study were not adjusted for education. In the second stage, the study-specific adjusted ORs
were pooled to create a summary OR, using random effects models. We used the I2 statistic
to assess heterogeneity between studies (23). Larger I2 values reflect increasing
heterogeneity, beyond what is attributable to chance. I2 values of 25%, 50% and 75% were
used as evidence of low, moderate, or high levels of heterogeneity, respectively. The
referent group for analyses of total alcohol and beverage-specific consumption was non-
drinkers of any alcohol type. For each of the beverage-specific analyses, we adjusted for
total alcohol consumption in an attempt to investigate specific effects independent of ethanol
content.
We calculated the P-value for trend by fitting alcohol consumption as an ordinal variable
and assigning participants the median value for their category of alcohol exposure.
Restricted cubic spline models were used to further investigate the continuous association
between alcohol consumption and the risk of Barrett’s esophagus (24). These models allow
for easy visualization of nonlinear associations (25, 26) and were plotted using a linear scale
on the x-axis (drinks/day of alcohol) and a logarithmic scale on the y-axis for the OR.
Finally, using the same methodology as for the overall analyses, we conducted stratified
analyses by categories of sex, BMI, GERD symptoms, and smoking status to assess
potential effect modification. We included an interaction term in the full model to assess the
statistical significance of the difference in association across strata. All tests for statistical
significance were two-sided at α=0.05 and analyses were conducted using Stata 13.0
(StataCorp LP, College Station, TX).
RESULTS
The numbers of cases and controls, and summary data for total alcohol consumption by
study, are shown in Table 1. Across the studies, 11.3% to 28.8% of population-based
controls and 10.8% to 33.6% of GERD controls were non-drinkers. Median total alcohol
consumption among population-based controls who were drinkers ranged from 0.4 to 3.0
drinks per day across studies. Cases and controls from the FINBAR study had higher median
total alcohol consumption than cases and controls from the other four studies.
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All results contrast cases with population-based controls, unless otherwise noted. Overall,
there was a borderline statistically significant inverse association between any alcohol
consumption and risk of Barrett’s esophagus (any vs. non-drinkers, summary OR=0.77, 95%
CI 0.60–1.00, I2=0%). However, while participants who reported typically consuming 3–<5
drinks per day had statistically significant lower risk of Barrett’s esophagus (3–<5 drinks per
day vs. non-drinkers, summary OR=0.57, 95% CI 0.38–0.86), there were no statistically
significant associations with higher levels of alcohol consumption (5–<7 drinks per day,
summary OR=0.58, 95% CI 0.30–1.12; ≥7 drinks per day, summary OR=0.89, 95%CI 0.51–
1.55) and we found no evidence for a dose-response relationship (ptrend=0.72) (Table 2).
Study-specific estimates were homogeneous within each of the consumption categories
(Figure 1) and the relative risk patterns were generally similar between males (any vs. non-
drinkers, summary OR=0.78, 95% CI 0.56–1.08, I2=0%) and females (any vs. non-drinkers,
summary OR=0.76, 95% CI 0.50–1.16, I2=0%; P-interaction=0.96). Alcohol consumption
was not associated with risk of Barrett’s esophagus when cases were compared with GERD
controls (Table 2; Figure 2). The summary ORs, obtained by pooling study-specific ORs
adjusted for similar confounders, were similar to those obtained using an alternate analytic
strategy whereby all subjects were analyzed using a single-model (pooled) approach with
adjustment for harmonized confounders and study (data not shown). The spline models
suggest a nonlinear relationship between total alcohol consumption and risk of Barrett’s
esophagus (Figure 3).
When we analyzed beverage-specific consumption, there was a statistically significant
inverse association with any wine consumption (any vs. non-drinkers, summary OR=0.71,
95% CI 0.52–0.98, I2=0%), adjusted for total alcohol consumption. However, the test for
trend with increasing wine consumption was not statistically significant (ptrend=0.21). We
found no consistent associations between beer, liquor and risk of Barrett’s esophagus (Table
3). The results were similar when analyses were not adjusted for total alcohol consumption
(data not shown).
We evaluated whether BMI, GERD symptoms, or smoking modified the association
between alcohol consumption and risk of Barrett’s esophagus (Supplementary Table 1).
There was no effect modification of alcohol consumption on the risk of Barrett’s esophagus
across all categories of each risk factor.
DISCUSSION
In this large pooled analysis, alcohol consumption was not a risk factor for Barrett’s
esophagus. Compared with controls, average daily consumption of alcohol was moderately
lower among cases; however, we found no consistent statistically significant association
between alcohol consumption and the risk of Barrett’s esophagus and there was no evidence
for a dose-response relationship. In beverage-specific analyses adjusted for total alcohol
consumption, wine was associated with a moderately reduced risk of Barrett’s esophagus.
The association between alcohol and Barrett’s esophagus was not modified by other factors
(including sex, BMI, GERD, and smoking).
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Previous studies have reported associations between alcohol and risk of Barrett’s esophagus,
however results have been conflicting (12–20). One possible explanation for the conflicting
findings may be that individual studies have inadequate power to assess this association and
are prone to type II error. Summarizing these results into an overall risk estimate using only
published data is difficult given the different exposure categories, confounders and analyses
used in the published manuscripts. By contrast, in this study, we had access to individual
participant data from each of the five contributing studies, allowing us to control for the
same set of potential confounders, and standardized categories of alcohol exposure, allowing
for more consistent and robust risk estimates. In addition, the large sample size of the
consortial approach increased the statistical power to detect associations and interactions.
Studies of Barrett’s esophagus help to establish where risk factors act in the pathway to
esophageal adenocarcinoma, either in the development of Barrett’s esophagus or progression
from Barrett’s esophagus to cancer. A previous pooled analysis of 11 epidemiological
studies of esophageal adenocarcinoma in BEACON found suggestive evidence for an
inverse association between alcohol and risk of cancer (27). However, the summary risk
estimates were not statistically significant (expect for those consuming 0.5–<1.0 drinks/day)
and there was no dose-response relationship (ptrend=0.21). The results of our study of
Barrett’s esophagus, together with null associations reported for alcohol and risk of
progression from Barrett’s esophagus to esophageal adenocarcinoma (28, 29), provides
strong evidence that alcohol consumption is not a risk factor for developing Barrett’s
esophagus or progressing from Barrett’s esophagus to esophageal adenocarcinoma.
We observed some evidence for an inverse relationship with moderate levels of alcohol
consumption. It is possible, however, that this may be due, at least in part, to reverse
causation. If people with reflux symptoms tend to avoid drinking alcohol, for example, the
apparent protective effect may simply be the result of alcohol avoidance among
symptomatic cases. While the associations between alcohol and Barrett’s esophagus were
not modified by a history of GERD symptoms, we had only self-reported GERD symptoms
and the associations were attenuated and not statistically significant when cases were
compared with GERD controls. Conversely, one of the component studies found that heavy
alcohol consumption at age 21 years (well before diagnosis with Barrett’s esophagus) was
also inversely associated with risk of Barrett’s esophagus (16), which can be interpreted to
argue against reverse causality. There are plausible mechanisms by which alcohol — and
wine in particular — may protect against Barrett’s esophagus, such as from antioxidant
resveratrol (30), and reduction in insulin resistance or increased levels of lipoproteins (31).
However, as both white wine and red wine have been associated with lower risk of Barrett’s
esophagus (16, 18), resveratrol is unlikely to explain any inverse association.
This pooled analysis has several important strengths, including its large size and inclusion of
multiple largely population-based studies. Furthermore, we defined and constructed each
alcohol variable in the same way for each study and adjusted our analyses by a standard set
of variables known to be associated with Barrett’s esophagus. We found no evidence of
between-study heterogeneity or evidence that the associations with alcohol were modified
by BMI, GERD symptoms or cigarette smoking.
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There are several limitations to this pooled analysis. Most studies ascertained average adult
daily consumption, although some studies collected recent consumption and this may have
increased the possibility of the reference group of non-drinkers including former drinkers.
However, while this would somewhat attenuate the observed associations, it would not
explain the inverse association with alcohol. It is possible that our results may be affected by
recall and selection bias due to case-control design. However, the possibility of recall bias
was minimized as most studies recruited incident cases soon after diagnosis and subjects in
some of the studies were blinded regarding the topic of the study. While the FINBAR study
included both incident and prevalent cases, the associations observed in FINBAR were
similar to other studies that used only incident diagnoses. While our study is the largest to
date, we were still unable to examine the association in non-Caucasians and case numbers
were still small in some subgroups of the stratified analyses. Finally, we did not adjust our
analyses for diet. However, when two of the component studies adjusted for diet, it did not
attenuate the associations with alcohol (16, 17).
In contrast to esophageal squamous cell carcinoma, where alcohol is a strong risk factor
(27), alcohol consumption is not a risk factor for Barrett’s esophagus or esophageal
adenocarcinoma. Our findings indicate that alcohol cessation is unlikely to reduce the risk of
Barrett’s esophagus or esophageal adenocarcinoma. Capturing patients’ alcohol histories is
therefore unlikely to help improve clinical risk stratification for Barrett’s esophagus.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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1. WHAT IS CURRENT KNOWLEDGE
• Alcohol consumption is generally thought to confer higher risk of Barrett’s
esophagus
• However, the results from previously published studies have been inconsistent
2. WHAT IS NEW HERE
• Alcohol consumption is not a risk factor for Barrett’s esophagus
• The findings from this large pooled analysis should allay any fears that alcohol
consumption increases the risk of developing Barrett’s esophagus
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Forest plot of the association between alcohol consumption (drinks/day) and the risk of
Barrett’s esophagus for comparison with population-based controls. Odds ratios are shown
for each category of alcohol consumption relative to non-drinking and are adjusted for sex,
age (categorical: <50, 50 to <60, 60 to <70, ≥70), body mass index (categorical: <25, 25 to
30, ≥30), education, smoking status (never, former, current), and gastroesophageal reflux
symptoms (ever, never).
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Forest plot of the association between alcohol consumption (drinks/day) and the risk of
Barrett’s esophagus for comparison with GERD controls. Odds ratios are shown for each
category of alcohol consumption relative to non-drinking and are adjusted for sex, age
(categorical: <50, 50 to <60, 60 to <70, ≥70), body mass index (categorical: <25, 25 to 30,
≥30), education (except UNC), and smoking status (never, former, current).
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Restricted cubic spline models of the relationship between total alcohol consumption and
risk of Barrett’s esophagus for comparisons with (A) population-based controls and (B)
GERD controls. Plots are restricted to alcohol consumption between 0 and 10 drinks per day
for clarity and consistency.
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